Inactive Instrument
Quotes Cardium Therapeutics Inc NYSE
Stocks
CXM
US1419163043
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 22-03-29 | Gene Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 21-09-03 | Gene Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020 | CI |
Basic data
Market Cap (USD)
64
Free-Float
93.84 %
Free-Float capitalization (USD)
60
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 64 | |
| +1.29% | +3.46% | +6.43% | +16.36% | 49.47B | |
| +0.89% | +13.44% | +491.34% | +594.30% | 43.97B | |
| +3.08% | +14.42% | +24.57% | +81.39% | 39.6B | |
| +1.38% | +3.70% | +34.54% | +9.11% | 39.29B | |
| +0.85% | +10.32% | +21.22% | +47.64% | 32.43B | |
| +0.08% | +5.00% | - | - | 16.84B | |
| +1.99% | +5.08% | +38.70% | +125.08% | 16.49B | |
| +0.34% | +3.40% | +5.39% | +18.79% | 14.01B | |
| +3.56% | +19.98% | +86.23% | +27.29% | 12.77B | |
| Average | +1.50% | +7.32% | +88.55% | +115.00% | 26.49B | |
| Weighted average by Cap. | +1.48% | +7.06% | +107.88% | +140.07% |
Historical Quotes: Cardium Therapeutics Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- CRXM Stock
- CXM Stock
- Quotes Cardium Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
